Recurrent de novo mutations implicate novel genes underlying simplex autism risk

B. J. O'Roak, Holly Stessman, E. A. Boyle, K. T. Witherspoon, B. Martin, C. Lee, L. Vives, C. Baker, J. B. Hiatt, D. A. Nickerson, R. Bernier, J. Shendure, E. E. Eichler

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

Original languageEnglish (US)
Article number5595
JournalNature Communications
Volume5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Autistic Disorder
mutations
genes
Genes
Mutation
disorders
seizures
Point Mutation
Seizures
Therapeutics

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

O'Roak, B. J., Stessman, H., Boyle, E. A., Witherspoon, K. T., Martin, B., Lee, C., ... Eichler, E. E. (2014). Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nature Communications, 5, [5595]. https://doi.org/10.1038/ncomms6595

Recurrent de novo mutations implicate novel genes underlying simplex autism risk. / O'Roak, B. J.; Stessman, Holly; Boyle, E. A.; Witherspoon, K. T.; Martin, B.; Lee, C.; Vives, L.; Baker, C.; Hiatt, J. B.; Nickerson, D. A.; Bernier, R.; Shendure, J.; Eichler, E. E.

In: Nature Communications, Vol. 5, 5595, 01.01.2014.

Research output: Contribution to journalArticle

O'Roak, BJ, Stessman, H, Boyle, EA, Witherspoon, KT, Martin, B, Lee, C, Vives, L, Baker, C, Hiatt, JB, Nickerson, DA, Bernier, R, Shendure, J & Eichler, EE 2014, 'Recurrent de novo mutations implicate novel genes underlying simplex autism risk', Nature Communications, vol. 5, 5595. https://doi.org/10.1038/ncomms6595
O'Roak, B. J. ; Stessman, Holly ; Boyle, E. A. ; Witherspoon, K. T. ; Martin, B. ; Lee, C. ; Vives, L. ; Baker, C. ; Hiatt, J. B. ; Nickerson, D. A. ; Bernier, R. ; Shendure, J. ; Eichler, E. E. / Recurrent de novo mutations implicate novel genes underlying simplex autism risk. In: Nature Communications. 2014 ; Vol. 5.
@article{89dee65390d24f2ca165421eab99939b,
title = "Recurrent de novo mutations implicate novel genes underlying simplex autism risk",
abstract = "Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.",
author = "O'Roak, {B. J.} and Holly Stessman and Boyle, {E. A.} and Witherspoon, {K. T.} and B. Martin and C. Lee and L. Vives and C. Baker and Hiatt, {J. B.} and Nickerson, {D. A.} and R. Bernier and J. Shendure and Eichler, {E. E.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/ncomms6595",
language = "English (US)",
volume = "5",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Recurrent de novo mutations implicate novel genes underlying simplex autism risk

AU - O'Roak, B. J.

AU - Stessman, Holly

AU - Boyle, E. A.

AU - Witherspoon, K. T.

AU - Martin, B.

AU - Lee, C.

AU - Vives, L.

AU - Baker, C.

AU - Hiatt, J. B.

AU - Nickerson, D. A.

AU - Bernier, R.

AU - Shendure, J.

AU - Eichler, E. E.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

AB - Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84923328885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923328885&partnerID=8YFLogxK

U2 - 10.1038/ncomms6595

DO - 10.1038/ncomms6595

M3 - Article

C2 - 25418537

AN - SCOPUS:84923328885

VL - 5

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 5595

ER -